---
title: "Doxepin - Depressive Disorder"
sidebar: mydoc_sidebar
permalink: db01142-mesh-d003866-1.html
toc: false 
---


Path ID: `DB01142_MESH_D003866_1`
{% include image.html url="images/db01142-mesh-d003866-1.png" file="db01142-mesh-d003866-1.png" alt="db01142-mesh-d003866-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D004316">MESH:D004316 </a> | doxepin | Drug |
| <a href="https://identifiers.org/UniProt:P31645">UniProt:P31645 </a> | Sodium-dependent serotonin transporter | Protein |
| <a href="https://identifiers.org/UniProt:P23975">UniProt:P23975 </a> | Sodium-dependent noradrenaline transporter | Protein |
| <a href="https://identifiers.org/GO:0051610">GO:0051610 </a> | Serotonin uptake | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D012701">MESH:D012701 </a> | Serotonin | ChemicalSubstance |
| <a href="https://identifiers.org/GO:0051620">GO:0051620 </a> | Noradrenaline uptake | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D009638">MESH:D009638 </a> | Noradrenaline | ChemicalSubstance |
| <a href="https://identifiers.org/GO:0061533">GO:0061533 </a> | Norepinephrine secretion, neurotransmission | BiologicalProcess |
| <a href="https://identifiers.org/GO:0060096">GO:0060096 </a> | Serotonin secretion, neurotransmission | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D003866">MESH:D003866 </a> | Depressive disorder | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Doxepin | DECREASES ACTIVITY OF | Sodium-Dependent Serotonin Transporter |
| Doxepin | DECREASES ACTIVITY OF | Sodium-Dependent Noradrenaline Transporter |
| Sodium-Dependent Serotonin Transporter | PARTICIPATES IN | Serotonin Uptake |
| Sodium-Dependent Noradrenaline Transporter | PARTICIPATES IN | Noradrenaline Uptake |
| Noradrenaline Uptake | DECREASES ABUNDANCE OF | Noradrenaline |
| Serotonin Uptake | DECREASES ABUNDANCE OF | Serotonin |
| Serotonin | POSITIVELY CORRELATED WITH | Serotonin Secretion, Neurotransmission |
| Noradrenaline | POSITIVELY CORRELATED WITH | Norepinephrine Secretion, Neurotransmission |
| Serotonin Secretion, Neurotransmission | NEGATIVELY REGULATES | Depressive Disorder |
| Norepinephrine Secretion, Neurotransmission | NEGATIVELY REGULATES | Depressive Disorder |
|---------|-----------|---------|

Comment: Oral doxepin is approved for the depression and/or anxiety, psychotic depressive disorders with associated anxiety and insomnia. The inhibition of norepinephrine and serotonin at synaptic nerve terminals by doxepin is beleived to be MoA

Reference: 
  - [https://go.drugbank.com/drugs/DB01142](https://go.drugbank.com/drugs/DB01142)
  - [https://en.wikipedia.org/wiki/Doxepin](https://en.wikipedia.org/wiki/Doxepin)
  - [https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1628227/](https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1628227/)
